Index · Artikel · Getting personal: New tests aid drug performance

Getting personal: New tests aid drug performance

2009-07-31 4
   
Advertisement
résuméCHICAGO Better diagnostic tests and pressure to lower healthcare costs may finally usher in the era of personalized medicine, in which patients get drugs tailored to their genetic makeup, a new report suggests. Personalized medicine has been a resear
Advertisement

Getting personal: New tests aid drug performance


CHICAGO Better diagnostic tests and pressure to lower healthcare costs may finally usher in the era of personalized medicine, in which patients get drugs tailored to their genetic makeup, a new report suggests.

Personalized medicine has been a researcher's dream since 2003 when scientists completed the Human Genome Project -- a decade-long race to sequence all of the DNA in people.

Drug companies and regulators are now looking for tests that increase the odds a high-cost biotechnology drug will work. They are using biomarkers -- such as specific proteins or genes -- to design better and cheaper clinical trials, lowering the cost of drug development.

"The fruits of the Human Genome Project are finally going to give us better insights into what works, and doesn't work for people," said Dr. David Levy of PricewaterhouseCoopers, which released a report on Thursday predicting increasing alliances between drug and diagnostics firms.

Levy said many patients were prescribed drugs that may have no benefit at all. According to the report, the response rate to current drugs ranged from 20 to 75 percent, depending on the compound or condition.

"Potentially, we can be much more specific with respect to who should get a drug and who should not," he said.

The report said the diagnostics market could grow 5 percent a year to $50 billion by 2012. Sales of molecular diagnostics, which include tests that analyze DNA or the chemical messenger RNA, could double to $5 billion in 2012 from $2.6 billion in 2007.

TESTS BEFOREHAND

Some of that growth is being driven by regulators.

The report noted that regulatory agencies including the U.S. Food and Drug Administration and the European Medicines Agency were now requiring the use of "companion diagnostics" -- diagnostic tests patients must have before a certain medication can be prescribed.

So far, the FDA requires the use of companion diagnostic tests with Pfizer's HIV drug Selzentry or maraviroc; Bristol-Myers Squibb's Erbitux or cetuximab for colorectal cancer and its leukemia drug Sprycel or dasatinib; and Genentech and Roche's Herceptin or trastuzumab for breast cancer.

Last week, the FDA recommended genetic testing before AIDS patients take GlaxoSmithKline Plc's drug Ziagen.

In Europe, there are now 11 drugs -- including Ziagen or abacavir for HIV and Novartis' leukemia drug Tasigna or nilotinib -- that require the use of companion diagnostics.

Researchers at PricewaterhouseCoopers, a financial advisory and consulting firm, expect many more.

Diagnostics not only help ensure that patients who get drugs will benefit. Drug makers can use them to enrich clinical trials, cutting the costs of drug development, Tony Pillari, director of Healthcare Advisory Services at PricewaterhouseCoopers, said in a telephone interview.

"In drug development, time is money. If you can cut development times by even by a small percentage, it can result in huge cost savings," Pillari said.

"Diagnostics now make possible enriched clinical trials. Rather than picking a random population, you can segment the population to focus on the people who are most likely to respond," he said.

(Editing by Maggie Fox and Peter Cooney)

  • Getting personal: New tests aid drug performance

    Getting personal: New tests aid drug performance
    CHICAGO Better diagnostic tests and pressure to lower healthcare costs may finally usher in the era of personalized medicine, in which patients get drugs tailored to their genetic makeup, a new report suggests. Personalized medicine has been a resear
    2009-07-31 DRUGSDIAGNOSTICS
  • U.N. says millions still lack access to AIDS drugs

    U.N. says millions still lack access to AIDS drugs
    LONDON More than half of the 9.5 million people who need AIDS drugs cannot get them and 33 million people across the world are still infected with the virus that causes it, a United Nations report said on Wednesday. Access to drugs, counseling and te
    2009-09-30 AIDSPROGRESS
  • AIDS drug cocktails saving lives: study

    AIDS drug cocktails saving lives: study
    NEW YORK (Reuters Health) - Taking a cocktail of powerful AIDS drugs appears to have cut the average death rate by half in a group of people infected with HIV, the virus that causes AIDS, who were followed for an average of more than three years. In
    2010-01-04 AIDSCOCKTAILS
  • NIH joins patent pool for AIDS drugs

    NIH joins patent pool for AIDS drugs
    LONDON The United States National Institutes of Health said on Thursday it will share intellectual property rights on some AIDS drugs in a patent pool designed to make treatments more widely available to the poor. The NIH is the first research instit
    2010-09-30 AIDSDRUGSPATENTS
  • Generics deal cuts cost of AIDS drugs for poor

    Generics deal cuts cost of AIDS drugs for poor
    LONDON A global health development partnership said on Tuesday it had secured price reductions on key AIDS drugs for HIV-positive patients in poorer countries. The Boston-based Clinton Health Access Initiative, Geneva's UNITAID, and the British gover
    2011-05-18 AIDSDRUGS
  • AIDS drugs can cause premature ageing: study

    AIDS drugs can cause premature ageing: study
    LONDON A class of generic AIDS drugs often used to treat HIV in Africa and other poor regions can cause premature aging and lead to age-related illnesses such as heart disease and dementia, scientists said on Sunday. In a study in the journal Nature
    2011-06-26 DRUGSHIVAGEING
  • HIV numbers hit new high as AIDS drugs save lives

    HIV numbers hit new high as AIDS drugs save lives
    LONDON More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS program (UNAIDS) said on Monday. In its annual report on the p
    2011-11-21 AIDSGLOBALUNAIDS
  • Children with HIV in Asia suffer resistance to AIDS drugs

    Children with HIV in Asia suffer resistance to AIDS drugs
    HONG KONG Teenagers in Asia receiving treatment for HIV are showing early signs of osteoporosis and children as young as five are becoming resistant to AIDS drugs, an anti-AIDS group said on Thursday, urging more attention be given to young HIV patie
    2011-12-01 CHILDRENAIDSASIA
  • GlaxoSmithKline unit joins patent pool for AIDS drugs

    GlaxoSmithKline unit joins patent pool for AIDS drugs
    LONDON GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries. ViiV Healthcare, majority-owned by GSK, is the seco
    2013-02-27 AIDSDRUGSPATENTS
  • Some South African clinics running short of HIV/AIDS drugs: MSF

    Some South African clinics running short of HIV/AIDS drugs: MSF
    JOHANNESBURG One in five South African clinics are running short of life-saving HIV/AIDS drugs, affecting nearly half a million people and undermining the success of the world's largest treatment program, medical charities said on Thursday. With abou
    2013-11-28 AIDSSAFRICA
  • GSK raises bet on AIDS drug with new Shionogi deal

    GSK raises bet on AIDS drug with new Shionogi deal
    LONDON/TOKYO GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan's Shionogi which gives it a much bigger economic interest in the new product. Dolutegravir, a once-daily drug that has performed strongly
    2012-10-29 HIVGSKShionogi
  • U.S. rolls back AIDS drug prevention trial in Botswana

    U.S. rolls back AIDS drug prevention trial in Botswana
    WASHINGTON U.S. officials said on Thursday they will give up on a trial in Botswana that was trying to show whether it is possible to prevent HIV infections by taking a daily pill because too few people are being infected. There are also problems kee
    2009-12-18 AIDSTRIAL
  • HIV/AIDS drug puzzle cracked

    HIV/AIDS drug puzzle cracked
    LONDON Scientists say they have solved a crucial puzzle about the AIDS virus after 20 years of research and that their findings could lead to better treatments for HIV. British and U.S. researchers said they had grown a crystal that enabled them to s
    2010-02-01 AIDSHIVENZYME
  • Millions will die if India stops AIDS drugs: U.N.

    Millions will die if India stops AIDS drugs: U.N.
    NEW DELHI Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday. The EU and India
    2011-07-05 AIDSINDIADRUGS
  • Using AIDS drugs to prevent infection: a bargain?

    Using AIDS drugs to prevent infection: a bargain?
    CHICAGO Giving an AIDS-fighting drug to men who are at high risk of HIV infection would cost billions, but it might be worth it terms of reducing infection rates, U.S. researchers said on Monday. Since 2010, when a landmark study in the New England J
    2012-04-16 AIDSDRUGS
  • AbbVie adds children's AIDS drugs to shared patent pool

    AbbVie adds children's AIDS drugs to shared patent pool
    LONDON U.S. drugmaker AbbVie has added two HIV medicines for children to a shared patent pool in an initiative that should speed the development of cheap new pediatric formulations for use in poor countries. It is the latest win for the non-profit Me
  • Sanofi's dual-action biotech asthma drug performs well in test

    Sanofi's dual-action biotech asthma drug performs well in test
    n">An experimental biotech drug for moderate to severe asthma from France's Sanofi and its U.S. partner Regeneron has produced good results in clinical tests, suggesting that its dual-action mechanism may be highly effective. The encouraging data
    2014-11-11 ASTHMASANOFI
  • Marinol (Dronabinol) - HIV / AIDS Drug Information

    Marinol (Dronabinol) - HIV / AIDS Drug Information
    Marinol (Dronabinol) ist ein verschreibungspflichtiges Medikament von Marihuana abgeleitet sind, die früher häufig bei Menschen mit HIV-assoziierter Wasting-Syndrom verschrieben wurde. Während seine Verwendungen zu denen von medizinischem Marihuana ä
  • "Harm reduction" needed to cut drug-user AIDS risk

    "Harm reduction" needed to cut drug-user AIDS risk
    LONDON Barely a twentieth of the estimated $3.2 billion needed is put into preventing drug users spreading the AIDS virus, experts said on Monday, and the shortfall is fuelling HIV epidemics in parts of Europe and Asia. In a report on the use of "har
    2010-04-26 AIDSHARMREDUCTION
  • AIDS gel with Gilead drug protects women in study

    AIDS gel with Gilead drug protects women in study
    VIENNA A gel containing a prescription drug can sharply reduce HIV infections in women, a study described as groundbreaking by the World Health Organization showed on Monday. The gel, containing Gilead Sciences AIDS drug tenofovir, reduced HIV infect
    2010-07-19 AIDSGEL

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated